Literature DB >> 647566

Malignant hypertension.

E Z Rabin.   

Abstract

Malignant or accelerated hypertension is a life-threatening disease whose complications may be prevented by rapid reduction of the blood pressure. Diazoxide is presently regarded as the preferred therapeutic agent, but drugs such as trimethaphan, sodium nitroprusside, phenoxybenzamine and hydralazine may be useful in particular situations. Treatment is best carried out in an intensive care unit, where appropriate monitoring and study of the patient can be done. Since the introduction of antihypertensive agents the life expectancy of these patients, even those with renal insufficiency, has increased.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647566      PMCID: PMC1818240     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  11 in total

1.  Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

Authors:  M HARINGTON; P KINCAID-SMITH; J McMICHAEL
Journal:  Br Med J       Date:  1959-11-14

2.  The clinical course and pathology of hypertension with papilloedema (malignant hypertension).

Authors:  P KINCAID-SMITH; J McMICHAEL; E A MURPHY
Journal:  Q J Med       Date:  1958-01

Review 3.  Hypertensive emergencies.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

4.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

5.  Vasodilation for vasopastic hypertension.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

6.  The importance of the rapid administration of diazoxide in accelerated hypertension.

Authors:  W J Mroczek; B A Leibel; M Davidov; F A Finnerty
Journal:  N Engl J Med       Date:  1971-09-09       Impact factor: 91.245

7.  Management of malignant hypertension complicated by renal insufficiency.

Authors:  J W Woods; W B Blythe
Journal:  N Engl J Med       Date:  1967-07-13       Impact factor: 91.245

8.  Hypertensive vascular disease. The long term effect of rapid repeated reductions of arterial pressure with diazoxide.

Authors:  F A Finnerty; M Davidov; N Kakaviatos
Journal:  Am J Cardiol       Date:  1967-03       Impact factor: 2.778

9.  Studies on the control of hypertension. 8. Mortality, morbidity, and remissions during twelve years of intensive therapy.

Authors:  H M Perry; H A Schroeder; F J Catanzaro; D Moore-Jones; G H Camel
Journal:  Circulation       Date:  1966-06       Impact factor: 29.690

10.  The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat.

Authors:  F B BYROM
Journal:  Lancet       Date:  1954-07-31       Impact factor: 79.321

View more
  1 in total

1.  Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases.

Authors:  N M Bennett; S Shea
Journal:  Am J Public Health       Date:  1988-06       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.